Khalid Saad Alharbi

8PUBLICATIONS
36CO-AUTHORS
Human impacts of climate change and human adaptationMetabolic medicineMolecular targetsPowder and particle technologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 29, 2026
Hypophyllanthin Protects Against Alcohol-Induced Hepatotoxicity in Rats: Involvement of Oxidative Stress, Inflammatory Cytokines, Apoptosis, and Autophagy.

|Jan 05, 2026
Marmelosin Protects Against Metabolic Disturbances in High-Fat Diet and Streptozotocin-Induced Diabetes.

Sattam Khulaif Alenezi, Khalid S Alharbi, Tariq G Alsahli

|Jan 20, 2023
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations.

Arafa Musa, Saleh K Ihmaid, David L Hughes

|Dec 28, 2021
Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment.

Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam

|Nov 14, 2021
EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.

Shumin Li, Zhongkai Xu, Majed Alrobaian

|Sep 01, 2021
Anticonvulsant effects of desvenlafaxine on modulating brain monoamine and oxidative stress in mice.

Khalid Saad Alharbi

Pageof 2

Frequent Collaborators

2 joint publications

Imran Kazmi

2 joint publications

Sultan Alshehri

2 joint publications

Sattam Khulaif Alenezi

2 joint publications

Syed Sarim Imam